{'fraction_non_alphanumeric': 0.03460837887067395, 'fraction_numerical': 0.00273224043715847, 'mean_word_length': 5.955696202531645, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Porphyrin Alternating Copolymer Vesicles for Photothermal Drug-Resistant Bacterial Ablation and Wound Disinfection.

In the past two decades, polymer vesicles have aroused widespread interest and made significant developments. However, the applications of polymer vesicles in anti-infective therapy are still limited. Here, we construct a polymer vesicle (TPPBV) from a porphyrin alternating copolymer P(TPP-a-BDE) with a high photothermal conversion efficiency (54.1%), which is attributed to the unique chain-folding mechanisms of the alternating copolymer. In particular, TPPBVs exhibit great photothermal antibacterial activity against both Gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and Gram-negative extended-spectrum β-lactamases Escherichia coli (ESBL E. coli). Moreover, TPPBVs present a specific antibiofilm effect, and they also have remarkable therapeutic effects in vivo on an MRSA-infected mice model. We believe that the porphyrin alternating copolymer vesicles for photothermal bacterial ablation reported here will extend the applications of polymer vesicles.